Aligned Genetics, Inc. (KOSDAQ:238120)
South Korea · Delayed Price · Currency is KRW 2,660.00
-90.00 (-3.27%)
At close: Oct 8, 2026
Aligned Genetics Ratios and Metrics
Market cap in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 37,821 | 54,406 | 43,496 | 57,947 | 54,137 | 61,614 | |
Market Cap Growth | -20.87% | 25.08% | -24.94% | 7.04% | -12.13% | -13.43% |
Enterprise Value | 37,351 | 41,561 | 31,551 | 48,198 | 44,338 | 52,552 |
Last Close Price | 2660.00 | 3870.00 | 3025.00 | 4030.00 | 3765.00 | 4285.00 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.08 | 18.69 | 10.54 | 17.91 | 23.21 | 11.12 |
PS Ratio | 2.34 | 3.40 | 2.76 | 3.81 | 3.94 | 5.24 |
PB Ratio | 0.96 | 1.46 | 1.23 | 1.85 | 1.88 | 2.28 |
P/TBV Ratio | 0.97 | 1.47 | 1.23 | 1.85 | 1.88 | 2.29 |
P/FCF Ratio | - | - | 15.49 | 29.41 | 244.98 | - |
P/OCF Ratio | 12.48 | 15.09 | 14.19 | 20.34 | 24.36 | 453.15 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 2.31 | 2.60 | 2.00 | 3.17 | 3.22 | 4.47 |
EV/EBITDA Ratio | 11.60 | 13.62 | 9.40 | 12.15 | 12.67 | 19.34 |
EV/EBIT Ratio | 14.78 | 17.01 | 11.35 | 14.44 | 15.56 | 24.12 |
EV/FCF Ratio | - | - | 11.24 | 24.47 | 200.64 | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.38 | 0.39 | 0.08 | 0.15 | 0.15 | 0.16 |
Debt / EBITDA Ratio | 4.65 | 4.75 | 0.88 | 1.18 | 1.25 | 1.63 |
Debt / FCF Ratio | - | - | 1.06 | 2.37 | 19.82 | - |
Net Debt / Equity Ratio | -0.01 | 0.00 | -0.41 | -0.33 | -0.32 | -0.32 |
Net Debt / EBITDA Ratio | -0.15 | -0.04 | -4.37 | -2.59 | -2.66 | -3.20 |
Net Debt / FCF Ratio | 0.06 | 0.02 | -5.23 | -5.21 | -42.16 | 2.74 |
Asset Turnover | 0.31 | 0.31 | 0.37 | 0.39 | 0.39 | 0.39 |
Inventory Turnover | 0.84 | 1.04 | 1.15 | 1.20 | 1.64 | 1.98 |
Quick Ratio | 4.05 | 3.93 | 10.86 | 3.37 | 11.38 | 10.98 |
Current Ratio | 5.43 | 5.08 | 13.49 | 4.12 | 14.67 | 12.97 |
Return on Equity (ROE) | 12.57% | 8.01% | 12.36% | 10.76% | 8.36% | 22.87% |
Return on Assets (ROA) | 3.03% | 2.99% | 4.08% | 5.36% | 4.99% | 4.54% |
Return on Invested Capital (ROIC) | 6.59% | 8.44% | 12.07% | 15.54% | 14.39% | 15.16% |
Return on Capital Employed (ROCE) | 4.50% | 4.60% | 6.60% | 9.30% | 8.00% | 6.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 7, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 12.27% | 5.35% | 9.49% | 5.58% | 4.31% | 8.99% |
FCF Yield | -20.88% | -13.71% | 6.46% | 3.40% | 0.41% | -5.15% |
Buyback Yield / Dilution | 1.11% | 1.85% | -0.03% | - | - | -38.26% |